Neuberger Berman Group
VERA icon

Neuberger Berman Group’s Vera Therapeutics VERA Stock Holding History

Neuberger Berman Group’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$323K Buy
+8,031
New +$346K ﹤0.01% 1805

Other funds holding VERA

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Neuberger Berman Group's VERA Position: Q1 2026 in Review

Neuberger Berman Group opened a new position in Vera Therapeutics (VERA) in Q1 2026: 8,031 shares worth $323K. The stake represents ﹤0.01% of the portfolio and ranks #1805 among its holdings.

229 funds tracked by Wall St. Rank hold VERA as of Q1 2026.

  • Neuberger Berman Group held 8,031 shares of Vera Therapeutics worth $323K as of Q1 2026.
  • Vera Therapeutics was a new Neuberger Berman Group position in Q1 2026.
  • Vera Therapeutics made up ﹤0.01% of Neuberger Berman Group's portfolio in Q1 2026, its #1805 holding.
  • 229 funds tracked by Wall St. Rank held Vera Therapeutics as of Q1 2026.

Based on Neuberger Berman Group's 13F filing for Q1 2026, filed 14 May 2026.